Abstract:Down syndrome (DS) is the most example of aneuploidy, resulting from an additional copy of all or part of chromosome 21. Competing endogenous RNAs (ceRNAs) play important roles in neuronal development and neurological defects. This study aimed to identify hub genes and synergistic crosstalk among ceRNAs in the DS fetal hippocampus as potential targets for the treatment of DS-related neurodegenerative diseases. We profiled differentially expressed long non-coding RNAs (DElncRNAs), differentially expressed circular RNAs (DEcircRNAs), differentially expressed microRNAs (DEmiRNAs), and differentially expressed messenger RNAs (DEmRNAs) in hippocampal samples from patients with or without DS. Functional enrichment analysis and gene set enrichment analysis were performed, and chromosome 21-related ceRNA and protein–protein interaction networks were constructed. Additionally, the correlations between lncRNA-mRNA and miRNA-mRNA expression in the samples and HEK293T cells were validated. Our finding of changes in the expression of some key genes and ncRNAs on chromosome 21 in DS might not fully conform to the gene dosage hypothesis. Moreover, we found that four lncRNAs ( MIR99AHG , PLCB4 , SNHG14 , GIGYF2 ) and one circRNA ( hsa_circ_0061697 ) may competitively bind with three miRNAs ( hsa-miR-548b-5p , miR-730-5p , and hsa-miR-548i ) and subsequently regulate five mRNAs ( beta-1,3-galactosyltransferase 5 [ B3GALT5 ], helicase lymphoid-specific [ HELLS ], thrombospondin-2 [ THBS2 ], glycinamide ribonucleotide transformylase [ GART ], clathrin heavy chain like 1 [ CLTCL1 ]). These RNAs, whether located on chromosome 21 or not, interact with each other and might activate the PI3K/Akt/mTOR and Wnt signaling pathways, which are involved in autophagosome formation and tau hyperphosphorylation, possibly leading to adverse consequences of trisomy 21. These findings provide researchers with a better understanding of the fundamental molecular mechanisms underlying DS-related progressive defects in neuronal development.

Altered neuronal network activity and connectivity in human Down Syndrome excitatory cortical neurons

Human Chromosome 21 Orthologous Region on Mouse Chromosome 17 is a Major Determinant of Down Syndrome-Related Developmental Cognitive Deficits.

Deficits in Human Trisomy 21 Ipscs and Neurons

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination

Consequences of trisomy 21 for brain development in Down syndrome

In vivo modeling of human neuron dynamics and Down syndrome

Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Single-cell RNA Sequencing of Neural Stem Cells Derived from Human Trisomic Ipscs Reveals the Abnormalities During Neural Differentiation of Down Syndrome.

Single-nucleus RNA sequencing reveals cell type-specific transcriptome alterations of Down syndrome hippocampus using the Dp16 mouse model

Competing Endogenous RNAs Crosstalk in Hippocampus: A Potential Mechanism for Neuronal Developing Defects in Down Syndrome

The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome

Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome

Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation

DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models

Transcriptional consequences of trisomy 21 on neural induction

Investigating brain alterations in the Dp1Tyb mouse model of Down syndrome

Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease

A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction

Cognitive and molecular characterization of the Ts66Yah murine model of Down syndrome: deepening on hippocampal changes associated with genotype and aging